Cargando…
Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study
Baclofen has been suggested as a potential pharmacotherapy for alcohol use disorder, but the clinical data are conflicting. Here we investigated the biobehavioral effects of baclofen in a sample of anxious alcohol-dependent individuals. This was a randomized, double-blind, placebo-controlled, human...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416708/ https://www.ncbi.nlm.nih.gov/pubmed/28440812 http://dx.doi.org/10.1038/tp.2017.71 |
_version_ | 1783233803940003840 |
---|---|
author | Farokhnia, M Schwandt, M L Lee, M R Bollinger, J W Farinelli, L A Amodio, J P Sewell, L Lionetti, T A Spero, D E Leggio, L |
author_facet | Farokhnia, M Schwandt, M L Lee, M R Bollinger, J W Farinelli, L A Amodio, J P Sewell, L Lionetti, T A Spero, D E Leggio, L |
author_sort | Farokhnia, M |
collection | PubMed |
description | Baclofen has been suggested as a potential pharmacotherapy for alcohol use disorder, but the clinical data are conflicting. Here we investigated the biobehavioral effects of baclofen in a sample of anxious alcohol-dependent individuals. This was a randomized, double-blind, placebo-controlled, human laboratory study in non-treatment seeking alcohol-dependent individuals with high trait anxiety (N=34). Participants received baclofen (30 mg per day) or placebo for at least 8 days, then performed an experimental session consisting of alcohol cue-reactivity followed by alcohol administration procedure (alcohol priming, then alcohol self-administration). Total amount of alcohol self-administered was the primary outcome; alcohol craving, subjective/physiological responses and mood/anxiety symptoms were also evaluated. There was no significant medication effect on the total amount of alcohol consumed during the alcohol self-administration (P=0.76). Baclofen blunted the positive association between maximum breath alcohol concentration during priming and the amount of alcohol consumption (significant interaction, P=0.03). Ratings of feeling intoxicated were significantly higher in the baclofen group after consuming the priming drink (P=0.006). During the self-administration session, baclofen significantly increased ratings of feeling high (P=0.01) and intoxicated (P=0.01). A significant reduction in heart rate (P<0.001) and a trend-level increase in diastolic blood pressure (P=0.06) were also detected in the baclofen group during the alcohol laboratory session. In conclusion, baclofen was shown to affect subjective and physiological responses to alcohol drinking in anxious alcohol-dependent individuals. These results do not support an anti-craving or anti-reinforcing effect of baclofen, but rather suggest that baclofen may act as a substitution medication for alcohol use disorder. |
format | Online Article Text |
id | pubmed-5416708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-54167082017-05-16 Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study Farokhnia, M Schwandt, M L Lee, M R Bollinger, J W Farinelli, L A Amodio, J P Sewell, L Lionetti, T A Spero, D E Leggio, L Transl Psychiatry Original Article Baclofen has been suggested as a potential pharmacotherapy for alcohol use disorder, but the clinical data are conflicting. Here we investigated the biobehavioral effects of baclofen in a sample of anxious alcohol-dependent individuals. This was a randomized, double-blind, placebo-controlled, human laboratory study in non-treatment seeking alcohol-dependent individuals with high trait anxiety (N=34). Participants received baclofen (30 mg per day) or placebo for at least 8 days, then performed an experimental session consisting of alcohol cue-reactivity followed by alcohol administration procedure (alcohol priming, then alcohol self-administration). Total amount of alcohol self-administered was the primary outcome; alcohol craving, subjective/physiological responses and mood/anxiety symptoms were also evaluated. There was no significant medication effect on the total amount of alcohol consumed during the alcohol self-administration (P=0.76). Baclofen blunted the positive association between maximum breath alcohol concentration during priming and the amount of alcohol consumption (significant interaction, P=0.03). Ratings of feeling intoxicated were significantly higher in the baclofen group after consuming the priming drink (P=0.006). During the self-administration session, baclofen significantly increased ratings of feeling high (P=0.01) and intoxicated (P=0.01). A significant reduction in heart rate (P<0.001) and a trend-level increase in diastolic blood pressure (P=0.06) were also detected in the baclofen group during the alcohol laboratory session. In conclusion, baclofen was shown to affect subjective and physiological responses to alcohol drinking in anxious alcohol-dependent individuals. These results do not support an anti-craving or anti-reinforcing effect of baclofen, but rather suggest that baclofen may act as a substitution medication for alcohol use disorder. Nature Publishing Group 2017-04 2017-04-25 /pmc/articles/PMC5416708/ /pubmed/28440812 http://dx.doi.org/10.1038/tp.2017.71 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Original Article Farokhnia, M Schwandt, M L Lee, M R Bollinger, J W Farinelli, L A Amodio, J P Sewell, L Lionetti, T A Spero, D E Leggio, L Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
title | Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
title_full | Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
title_fullStr | Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
title_full_unstemmed | Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
title_short | Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
title_sort | biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416708/ https://www.ncbi.nlm.nih.gov/pubmed/28440812 http://dx.doi.org/10.1038/tp.2017.71 |
work_keys_str_mv | AT farokhniam biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT schwandtml biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT leemr biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT bollingerjw biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT farinellila biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT amodiojp biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT sewelll biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT lionettita biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT sperode biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy AT leggiol biobehavioraleffectsofbaclofeninanxiousalcoholdependentindividualsarandomizeddoubleblindplacebocontrolledlaboratorystudy |